BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17218049)

  • 1. Acute dystonia resulting from abrupt bupropion discontinuation.
    Wang HY; Chou WJ; Huang TY; Hung CF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):766-8. PubMed ID: 17218049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute psychosis after administration of bupropion hydrochloride (Zyban)].
    Neumann M; Livak V; Paul HW
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S140-1. PubMed ID: 15570532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 5. Aphthous ulcers associated with bupropion in a female adolescent: a case verified by rechallenge.
    Chiang CK; Chou YH; Chen YH; Sha CB; Liang CS
    Gen Hosp Psychiatry; 2011; 33(4):411.e1-2. PubMed ID: 21762840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
    Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
    Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for amphetamine withdrawal syndrome.
    Chan-Ob T; Kuntawongse N; Boonyanaruthee V
    J Med Assoc Thai; 2001 Dec; 84(12):1763-5. PubMed ID: 11999825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of bupropion-induced stuttering.
    Fetterolf F; Marceau M
    Gen Hosp Psychiatry; 2013; 35(5):574.e7-8. PubMed ID: 22959418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypomania/mania induced by cessation of antidepressant drugs].
    Kora K; Kaplan P
    Turk Psikiyatri Derg; 2008; 19(3):329-33. PubMed ID: 18791886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation.
    Surovik J; Riddel C; Chon SY
    J Drugs Dermatol; 2010 Aug; 9(8):1010-2. PubMed ID: 20684153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion-induced psychosis.
    Howard WT; Warnock JK
    Am J Psychiatry; 1999 Dec; 156(12):2017-8. PubMed ID: 10588428
    [No Abstract]   [Full Text] [Related]  

  • 13. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H; Butt MA
    Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
    [No Abstract]   [Full Text] [Related]  

  • 14. Bupropion-induced acute dystonia.
    Detweiler MB; Harpold GJ
    Ann Pharmacother; 2002 Feb; 36(2):251-4. PubMed ID: 11847943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration.
    Bagshaw SM; Cload B; Gilmour J; Leung ST; Bowen TJ
    Ann Allergy Asthma Immunol; 2003 May; 90(5):572-5. PubMed ID: 12775141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
    Liu CY; Chien YS
    J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects associated with extra doses of bupropion.
    Shepherd G
    Pharmacotherapy; 2005 Oct; 25(10):1378-82. PubMed ID: 16185182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.